Abstract
Background: The RCPA has recently published new Australasian guidelines for thyroid cytology reporting in order to provide a standardised approach. The new system, based on a framework of the Bethesda system, aims to be practical, reproducible and provide relevant guidance to clinicians on management options.Aims: To assess if ratios of categories of thyroid biopsies using the new Australasian guidelines are the same as those recorded using older systems of classification.Methods: All thyroid FNA biopsies reported from Flinders Medical Centre between July 2012 and July 2015 were retrieved from the Delphic database and analysed using Microsoft Excel.Results and discussion: Of 387 biopsies reviewed, most (63%) were assessed as RCPA Category 2/Benign, 11% as Category 1, 5% as Category 3, 6% as Category 4, 2% as Category 5 and 3% as Category 6. Findings largely matched the expected proportions of biopsies quoted to fall in each category by the 2014 RCPA Protocol.1 These results support the continued use of the new Australasian guidelines at FMC.Reference1.Royal College of Pathologists Australasia. Thyroid Cytology: Structured Reporting Protocol. 1st Edition 2014. Sydney: RCPA, 2014. Background: The RCPA has recently published new Australasian guidelines for thyroid cytology reporting in order to provide a standardised approach. The new system, based on a framework of the Bethesda system, aims to be practical, reproducible and provide relevant guidance to clinicians on management options. Aims: To assess if ratios of categories of thyroid biopsies using the new Australasian guidelines are the same as those recorded using older systems of classification. Methods: All thyroid FNA biopsies reported from Flinders Medical Centre between July 2012 and July 2015 were retrieved from the Delphic database and analysed using Microsoft Excel. Results and discussion: Of 387 biopsies reviewed, most (63%) were assessed as RCPA Category 2/Benign, 11% as Category 1, 5% as Category 3, 6% as Category 4, 2% as Category 5 and 3% as Category 6. Findings largely matched the expected proportions of biopsies quoted to fall in each category by the 2014 RCPA Protocol.1 These results support the continued use of the new Australasian guidelines at FMC. Reference1.Royal College of Pathologists Australasia. Thyroid Cytology: Structured Reporting Protocol. 1st Edition 2014. Sydney: RCPA, 2014.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call